See also this year's filing and all EDGAR filings for this company.
PDF Report 0001322505_2012_Albireo_Pharma_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001322505, Albireo Pharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 39,196,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 49,000 |
| 2 | PropertyPlantAndEquipmentNet | 2,253,000 |
| 3 | remainder_Assets | 7,000 |
| 4 | LiabilitiesCurrent | 3,289,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 1,138,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,321,000 |
| 9 | ResearchAndDevelopmentExpense | 13,901,000 |
| 10 | remainder_Expenses | 119,000 |
| 11 | remainder_Revenues | 60,000 |
| 12 | remainder_NetIncome | 11,984,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 41,505,000 |
| 1 | Liabilities | 4,427,000 |
| 2 | Expenses | 23,341,000 |
| 3 | Revenues | 60,000 |
| 4 | StockholdersEquity | 37,078,000 |
| 5 | NetIncome | -11,297,000 |
| 6 | ComprehensiveNetIncome | -11,297,000 |
| 7 | BaseVar | 40,658,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.03 |
| 9 | EconomicCapitalRatio | 3.71 |
Edgar->Model Mapping
Feature Distribution
